Crohns Disease Treatment Market: By Drug Class (Antibiotics, Anti-Diarrheal, Immune System Suppressants, Analgesics, Anti-Inflammatory Drugs, Monoclonal Antibodies), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) and Geogarphy

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Crohn's Disease Treatment Market size valued at USD 800 million in 2022 and expected to reach USD 1088.7 million by 2028, at a significant CAGR of 4.5% from 2023-2029. A Crohns disease belongs to a condition called inflammatory bowel disease (IBD) that causes inflammation and damage to the digestive tract. Crohns disease usually affects at the end of small intestine and beginning of colon, but inflammation may occur anywhere along the digestive tract. crohns disease may be hereditary or develop due to the malfunctioning of the immune system. Currently there is no cure for crohn's disease. However, there are many treatments to manage disease symptoms. Inflammation, ulcers, bowel obstruction, malnutrition, colon cancer, and anal fissures are some of the complications associated with the disease. Surgery and drug therapy are some of the treatment options available to treat crohns disease. Some of the anti-inflammatory drugs used to treat crohns disease include, corticosteroids and oral 5-aminosalicylates. Global crohns disease treatment market is expected to grow at a significant rate during the forecast period.

Growth in biologics development unfolded the opportunities for the new market players as they are most commonly used in crohns disease treatment. Market players are focusing on to develop new products that can treat crohns disease. For instance, mongersen, is investigational therapy for the treatment of crohns disease, is being developed by Celgene Corporation in phase 3 clinical trials. Considering the foreseen factors crohns disease treatment market is projected to have a lucrative opportunity for market players. Manufacturers of Crohn's disease medications are concentrating on commercial distribution through retail pharmacies and online portals. Anti-inflammatory medications and corticosteroids are routinely distributed through these channels, both with and without a prescription. Consumers might also get savings when buying drugs in bulk through online platforms. The substantial rise of the anti-inflammatory medications segment of the global Crohn's disease market is mostly due to easy product availability and price cuts.

Global Crohns Disease Treatment Market Summary

Study Period

2023-29

Base Year

2022

CAGR

4.5%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Crohns Disease Market Dynamics

The prime driver for global crohns disease treatment market is increase in number of people being infected by the disease. In addition, increase in demand for biologics and high unmet needs within the anti-TNF refractory patient group that presents untapped market opportunities. Strong pipeline and novel mechanisms to treat crohns disease are fueling the growth of global crohns disease treatment market . However, patent expiry of the key drugs and high cost of treatment is expected to hamper the crohns disease treatment market globally. High R&D investment for development of biological drugs and unknown etiology of the crohns disease further hindering the market growth.

Key Features of the Reports

  • The crohns disease treatment market report provides granular level information about the market size, regional market share, historic market (2018-2022) and forecast (2023-2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Crohns Disease Treatment Market Segmentation

By Drug Class
  • Antibiotics
  • Anti-Diarrheal
  • Immune System Suppressants
  • Analgesics
  • Anti-Inflammatory Drugs
  • Monoclonal Antibodies
By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Others
By Geography
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Frequently Asked Questions

The Crohn’s disease treatment market size was valued at USD 800 million in 2022.

The Crohn’s disease treatment market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

The Crohn’s disease treatment market key players Allergan, Inc. (U.S.), AbbVie Inc., (U.S.), Takeda Pharmaceutical Company Limited (Japan), Bayer AG (Switzerland), UCB S.A. (Belgium), Perrigo Company plc (Ireland), Pfizer Inc. (U.S.), Johnson & Johnson Services, Inc. (U.S), Ferring B.V. (Switzerland)

1.Executive Summary
2.Global Crohns Disease Treatment Market Introduction 
2.1.Global Crohns Disease Treatment Market  - Taxonomy
2.2.Global Crohns Disease Treatment Market  - Definitions
2.2.1.Drug Class
2.2.2.Distribution Channel
2.2.3.Region
3.Global Crohns Disease Treatment Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Crohns Disease Treatment Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Crohns Disease Treatment Market  By Drug Class, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Antibiotics
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Anti-Diarrheal
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Immune System Suppressants
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Analgesics
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Anti-Inflammatory Drugs
5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Monoclonal Antibodies
5.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
6.Global Crohns Disease Treatment Market  By Distribution Channel, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Hospital Pharmacy
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Retail Pharmacy
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Others
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Crohns Disease Treatment Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.North America Crohns Disease Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. Drug Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Antibiotics
8.1.2.Anti-Diarrheal
8.1.3.Immune System Suppressants
8.1.4.Analgesics
8.1.5.Anti-Inflammatory Drugs
8.1.6.Monoclonal Antibodies
8.2.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Hospital Pharmacy
8.2.2.Retail Pharmacy
8.2.3.Others
8.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9.Europe Crohns Disease Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Antibiotics
9.1.2.Anti-Diarrheal
9.1.3.Immune System Suppressants
9.1.4.Analgesics
9.1.5.Anti-Inflammatory Drugs
9.1.6.Monoclonal Antibodies
9.2.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Hospital Pharmacy
9.2.2.Retail Pharmacy
9.2.3.Others
9.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
9.3.6.Rest of EU
10.Asia Pacific (APAC) Crohns Disease Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Antibiotics
10.1.2.Anti-Diarrheal
10.1.3.Immune System Suppressants
10.1.4.Analgesics
10.1.5.Anti-Inflammatory Drugs
10.1.6.Monoclonal Antibodies
10.2.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Hospital Pharmacy
10.2.2.Retail Pharmacy
10.2.3.Others
10.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11.Middle East and Africa (MEA) Crohns Disease Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Antibiotics
11.1.2.Anti-Diarrheal
11.1.3.Immune System Suppressants
11.1.4.Analgesics
11.1.5.Anti-Inflammatory Drugs
11.1.6.Monoclonal Antibodies
11.2.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Hospital Pharmacy
11.2.2.Retail Pharmacy
11.2.3.Others
11.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12.Latin America Crohns Disease Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Antibiotics
12.1.2.Anti-Diarrheal
12.1.3.Immune System Suppressants
12.1.4.Analgesics
12.1.5.Anti-Inflammatory Drugs
12.1.6.Monoclonal Antibodies
12.2.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Hospital Pharmacy
12.2.2.Retail Pharmacy
12.2.3.Others
12.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.Allergan, Inc. (U.S.)
13.2.2.AbbVie Inc., (U.S.)
13.2.3.Takeda Pharmaceutical Company Limited (Japan)
13.2.4.Bayer AG (Switzerland)
13.2.5.UCB S.A. (Belgium)
13.2.6.Perrigo Company plc (Ireland)
13.2.7.Pfizer Inc. (U.S.)
13.2.8.Johnson & Johnson Services, Inc. (U.S)
13.2.9.Ferring B.V. (Switzerland)
14. Research Methodology 
15. Appendix and Abbreviations 
  • Allergan, Inc. (U.S.)
  • AbbVie Inc., (U.S.)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Bayer AG (Switzerland)
  • UCB S.A. (Belgium)
  • Perrigo Company plc (Ireland)
  • Pfizer Inc. (U.S.)
  • Johnson & Johnson Services, Inc. (U.S)
  • Ferring B.V. (Switzerland)